These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 29300009)

  • 1. Structure of the complement C5a receptor bound to the extra-helical antagonist NDT9513727.
    Robertson N; Rappas M; Doré AS; Brown J; Bottegoni G; Koglin M; Cansfield J; Jazayeri A; Cooke RM; Marshall FH
    Nature; 2018 Jan; 553(7686):111-114. PubMed ID: 29300009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological characterisation of small molecule C5aR1 inhibitors in human cells reveals biased activities for signalling and function.
    Li XX; Lee JD; Massey NL; Guan C; Robertson AAB; Clark RJ; Woodruff TM
    Biochem Pharmacol; 2020 Oct; 180():114156. PubMed ID: 32682759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Orthosteric and allosteric action of the C5a receptor antagonists.
    Liu H; Kim HR; Deepak RNVK; Wang L; Chung KY; Fan H; Wei Z; Zhang C
    Nat Struct Mol Biol; 2018 Jun; 25(6):472-481. PubMed ID: 29867214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of Anaphylatoxin Receptor Expression and C3a/C5a Functions in Anaphylatoxin Receptor Reporter Mice.
    Laumonnier Y; Karsten CM; Köhl G; Köhl J
    Curr Protoc Immunol; 2020 Sep; 130(1):e100. PubMed ID: 32710701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure and characterization of a high affinity C5a monoclonal antibody that blocks binding to C5aR1 and C5aR2 receptors.
    Colley CS; Popovic B; Sridharan S; Debreczeni JE; Hargeaves D; Fung M; An LL; Edwards B; Arnold J; England E; Eghobamien L; Sivars U; Flavell L; Renshaw J; Wickson K; Warrener P; Zha J; Bonnell J; Woods R; Wilkinson T; Dobson C; Vaughan TJ
    MAbs; 2018 Jan; 10(1):104-117. PubMed ID: 28952876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular characterization of the gerbil C5a receptor and identification of a transmembrane domain V amino acid that is crucial for small molecule antagonist interaction.
    Waters SM; Brodbeck RM; Steflik J; Yu J; Baltazar C; Peck AE; Severance D; Zhang LY; Currie K; Chenard BL; Hutchison AJ; Maynard G; Krause JE
    J Biol Chem; 2005 Dec; 280(49):40617-23. PubMed ID: 16230349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partial ligand-receptor engagement yields functional bias at the human complement receptor, C5aR1.
    Pandey S; Li XX; Srivastava A; Baidya M; Kumari P; Dwivedi H; Chaturvedi M; Ghosh E; Woodruff TM; Shukla AK
    J Biol Chem; 2019 Jun; 294(24):9416-9429. PubMed ID: 31036565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement C5a Receptor 1 Exacerbates the Pathophysiology of
    Herrmann JB; Muenstermann M; Strobel L; Schubert-Unkmeir A; Woodruff TM; Gray-Owen SD; Klos A; Johswich KO
    mBio; 2018 Jan; 9(1):. PubMed ID: 29362231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural sequence evolution and computational modeling approaches of the complement system in leishmaniasis.
    Ingale P; Kabra R; Singh S
    Adv Protein Chem Struct Biol; 2020; 120():409-424. PubMed ID: 32085887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anaphylatoxin receptor promiscuity for commonly used complement C5a peptide agonists.
    Li XX; Clark RJ; Woodruff TM
    Int Immunopharmacol; 2021 Nov; 100():108074. PubMed ID: 34454293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural analysis of the human C5a-C5aR1 complex using cryo-electron microscopy.
    Yang T; Li J; Cheng X; Lu Q; Farooq Z; Fu Y; Lv S; Nan W; Yu B; Duan J; Zhang Y; Fu Y; Jiang H; McCormick PJ; Li Y; Zhang J
    J Struct Biol; 2024 Sep; 216(3):108117. PubMed ID: 39153560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental design of complement component 5a-induced acute lung injury (C5a-ALI): a role of CC-chemokine receptor type 5 during immune activation by anaphylatoxin.
    Russkamp NF; Ruemmler R; Roewe J; Moore BB; Ward PA; Bosmann M
    FASEB J; 2015 Sep; 29(9):3762-72. PubMed ID: 25999468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural complexes of the agonist, inverse agonist and antagonist bound C5a receptor: insights into pharmacology and signaling.
    Rana S; Sahoo AR; Majhi BK
    Mol Biosyst; 2016 Apr; 12(5):1586-99. PubMed ID: 26978009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and characterization of NDT 9513727 [N,N-bis(1,3-benzodioxol-5-ylmethyl)-1-butyl-2,4-diphenyl-1H-imidazole-5-methanamine], a novel, orally bioavailable C5a receptor inverse agonist.
    Brodbeck RM; Cortright DN; Kieltyka AP; Yu J; Baltazar CO; Buck ME; Meade R; Maynard GD; Thurkauf A; Chien DS; Hutchison AJ; Krause JE
    J Pharmacol Exp Ther; 2008 Dec; 327(3):898-909. PubMed ID: 18753409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement C5a Induces Pro-inflammatory Microvesicle Shedding in Severely Injured Patients.
    Karasu E; Demmelmaier J; Kellermann S; Holzmann K; Köhl J; Schmidt CQ; Kalbitz M; Gebhard F; Huber-Lang MS; Halbgebauer R
    Front Immunol; 2020; 11():1789. PubMed ID: 32983087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ras-Related Protein Rab5a Regulates Complement C5a Receptor Trafficking, Chemotaxis, and Chemokine Secretion in Human Macrophages.
    Wu KC; Condon ND; Hill TA; Reid RC; Fairlie DP; Lim J
    J Innate Immun; 2023; 15(1):468-484. PubMed ID: 36882040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aptamers that bind to the human complement component receptor hC5aR1 interfere with hC5aR1 interaction to its hC5a ligand.
    Kumar PKR
    Mol Biol Rep; 2018 Oct; 45(5):851-864. PubMed ID: 29981048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement C5aR1 Signaling Promotes Polarization and Proliferation of Embryonic Neural Progenitor Cells through PKCζ.
    Coulthard LG; Hawksworth OA; Li R; Balachandran A; Lee JD; Sepehrband F; Kurniawan N; Jeanes A; Simmons DG; Wolvetang E; Woodruff TM
    J Neurosci; 2017 May; 37(22):5395-5407. PubMed ID: 28455369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C5a mutants are potent antagonists of the C5a receptor (CD88) and of C5L2: position 69 is the locus that determines agonism or antagonism.
    Otto M; Hawlisch H; Monk PN; Müller M; Klos A; Karp CL; Köhl J
    J Biol Chem; 2004 Jan; 279(1):142-51. PubMed ID: 14570896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibiting the C5-C5a receptor axis.
    Woodruff TM; Nandakumar KS; Tedesco F
    Mol Immunol; 2011 Aug; 48(14):1631-42. PubMed ID: 21549429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.